The Annexure

News to 9 October 2026 ·

Desk›Textiles› Skybiotech Healthcare Ltd

Skybiotech Healthcare Ltd

BSE 512036 · NSE SKYBIOTECH · ISIN INE393H01016 · Group X · Active

Consumer Discretionary › Textiles › Textiles & Apparels › Other Textile Products

₹130.50

-0.46%

BSE close, 28 August 2026

Market cap

₹24.99 cr

0.2 cr shares · Micro cap

Free float

₹9.13 cr

as published

P/E · P/B

-621.4× · 2.20×

EPS ₹-0.21 · BV ₹59.32

FY25-26 rev / PAT

— / -0.06

₹ cr, as filed

Filings, window

7

2 selected · 29%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹116.45 52-WK HIGH ₹237.30 ₹130.50 12% of range
Against 52-week high-45.0%
Against 52-week low+12.1%
Day change-0.46%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-0.21
Price / earnings-621.43×
Price / book2.20×
Book value — derived, price ÷ P/B₹59.32
Return on equity-0.36%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
-0.35%
ROE as published
-0.36%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q — 0.00 0.46 — —
Mar-26 · Q — 0.01 -1.34 — —
FY25-26 — -0.06 -1.18 — —

Quarter on quarter

Net profit, quarter on quarter
-100.0%

Disclosure profile 7 filings in the window

0 median 14.0 sector max 48 7 8th percentile of 329 Textiles filers
Shaded is the middle half of the sector, 11 to 18 filings. Measured against the 329 Textiles companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM3
Board Meeting1
Trading Window1
Procedural sub-total5
Total7

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

7 filings · 2 selected · busiest 2026-08-14 and 2026-09-30

Filing rhythm · the twelve most recent

2026-08-112026-10-01

SelectedProcedural

Filings

7 in the window

  1. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Submission of Scrutinizer Report for the 43rd Annual General Meeting of Company held on 30th September, 2026

    AGM/EGM / AGM View filing →

  2. 1 October 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Trading Window closure to declared financial results for the Quarter ended on 30th September, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceeding of 43rd Annual general Meeting of members of Skybiotech Healthcare Limited

    AGM/EGM / AGM View filing →

  4. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 43rd Annual General Meeting of of SKYBIOTECH HEALTHCARE LIMITED held on 30th September, 2026

    AGM/EGM / AGM View filing →

  5. 14 August 2026 ·

    Results

    Un-Audited Financial Results For The Quarter Ended On 30Th June 2026

    Un-Audited Financial Results for the quarter ended on 30th June 2026

    Result / Financial Results View filing →

  6. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th August, 2026

    Outcome of Board Meeting dated 14th August, 2026 to considered and approved the Un-audited Financial Results of Company for the quarter ended on 30th June, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  7. 11 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Approval Of Un-Audited Financial Results And Limited Review Report Of The Company For The Quarter Ended On June 30, 2026.

    Skybiotech Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Un-Audited financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Skybiotech Healthcare Ltd · the 50 most recent filings